ライフサイエンスコーパス: cryoablation

1 and type of ablation (radiofrequency versus cryoablation).

2 .9 cm) in 12 patients were treated (18 total cryoablations).

3 ble for laparoscopic partial nephrectomy and cryoablation.

4 chemotherapy were treated with percutaneous cryoablation.

5 orted a reduction in these medications after cryoablation.

6 frequency, laser, microwave, ultrasound, and cryoablation.

7 nd tissue temperatures were monitored during cryoablation.

8 ion, microwave ablation, laser ablation, and cryoablation.

9 s were excised at lumpectomy 2-3 weeks after cryoablation.

10 may be indicators of likelihood of complete cryoablation.

11 onary vein stenosis appears to be lower with cryoablation.

12 pdate on the safety and efficacy of catheter cryoablation.

13 frequency, laser, microwave, ultrasound, and cryoablation.

14 images can be normal findings after hepatic cryoablation.

15 yonecrosis that were obtained 24 hours after cryoablation.

16 onography (US) were performed 7-8 days after cryoablation.

17 oventricular block in patients who underwent cryoablation.

18 f tissue necrosis is important when planning cryoablation.

19 One patient underwent primary cryoablation.

20 with 3 radiofrequency-failures/conversion to cryoablation.

21 r complications in patients undergoing renal cryoablation.

22 ful retreatment with MR imaging-guided focal cryoablation.

23 elivery are the goals of research in RFA and cryoablation.

24 androgen deprivation monotherapy to 74% for cryoablation.

25 cally lower than those seen with whole-gland cryoablation.

26 ither RF (30 W, 50 degrees C, 60 seconds) or cryoablation (-80 degrees C for 5 minutes).

27 Of the 163 patients randomized to cryoablation, 84 patients experienced ERAF (51.5%).

28 y, in the 22 patients who underwent surgical cryoablation, a single event occurred 7 years after PVR.

29 ved understanding of the mechanisms by which cryoablation affects innate and adaptive immunity will h

30 Cryoablation alone eliminated epicardial posteroseptal a

31 growth of secondary tumors was unaffected by cryoablation alone, the combination treatment was suffic

32 Catheter cryoablation also can be used to isolate the pulmonary v

33 recurrence at 6 months follow-up was 0% for cryoablation and 44% for radiofrequency (P=0.03).

34 d at core biopsy were treated with US-guided cryoablation and a 2.7-mm cryoprobe.

35 to local tumor recurrence even with combined cryoablation and CpG treatment.

36 Cryoablation and high-intensity focused ultrasound of th

37 tion is associated with the thawing phase of cryoablation and may be related to soluble mediator(s) r

38 Data are lacking on long-term outcomes from cryoablation and on the most effective balloon size.

39 Cryoablation and radio frequency ablation are effective

40 iterature demonstrating the effectiveness of cryoablation and radio frequency ablation performed lapa

41 Although the initial outcomes of cryoablation and radiofrequency ablation are encouraging

42 Three- and 4-year data for cryoablation and radiofrequency ablation are now becomin

43 Cryoablation and radiofrequency ablation are the two mos

44 Currently, cryoablation and radiofrequency ablation are the two mos

45 rimental and clinical, on the application of cryoablation and radiofrequency ablation for the treatme

46 Three- and five-year outcomes following cryoablation and radiofrequency ablation have recently b

47 term outcomes of probe-ablative therapy with cryoablation and radiofrequency ablation suggest satisfa

48 Cryoablation and radiofrequency ablation therapies have

49 of urologic tumors in the form of freezing (cryoablation) and heating (radiofrequency ablation) have

50 al-beam radiation, 13.3% brachytherapy, 4.0% cryoablation, and 14.4% androgen deprivation monotherapy

51 r induced thermotherapy, microwave ablation, cryoablation, and extracorporeal high-intensity focused

52 rrent trends towards nerve-sparing and focal cryoablation are also discussed.

53 te indicate that radiofrequency ablation and cryoablation are effective therapies with acceptable sho

54 dures such as transarterial embolization and cryoablation are leading to a new generation of patients

55 ion, microwave ablation, laser ablation, and cryoablation are reviewed with respect to the various cl

56 Most cryoablations are performed using a laparoscopic approac

57 Thermal therapeutic options, especially cryoablation, are of growing interest for the treatment

58 n Best Practice Guidelines identify prostate cryoablation as both primary and salvage therapies.

59 e success rates were 90% and 77% for RFA and cryoablation at the ideal site, respectively.

60 (A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atr

61 nal metastasis who were treated with adrenal cryoablation between May 2005 and October 2009 were elig

62 nd lung tissue samples of animals undergoing cryoablation but not after RFA, and serum cytokine level

63 respiratory distress syndrome (ARDS), after cryoablation but not RFA.

64 rates are universally high after whole-gland cryoablation, but incontinence and urethrorectal fistula

65 Hepatic cryoablation, but not RFA, induces NF-kappaB activation

66 Minimally-invasive, parenchyma-preserving cryoablation can be considered as a potential feasible o

67 Clinically, radio frequency ablation and cryoablation can be performed percutaneously or laparosc

68 iority of either radio frequency ablation or cryoablation cannot be confirmed based on available lite

69 Focal ablation was performed using an 8-mm cryoablation catheter or a 4-mm open-irrigated radiofreq

70 We also examined the efficacy and safety of cryoablation close to a CA.

71 rstand the mechanism of immune activation by cryoablation, comprehensive analyses of innate immunity

72 on renal radio frequency ablation (RFA) and cryoablation confirming their oncologic efficacy emerge,

73 , and in select high-risk patients, surgical cryoablation does not seem to increase arrhythmic events

74 a to select appropriate candidates for focal cryoablation due to the complexity of tumorigenesis in e

75 (79%) drug-treated patients crossed over to cryoablation during 12 months of study follow-up due to

76 After cryoablation, EADs from surviving epicardium (~1 mm) fir

77 Patients undergoing adrenal cryoablation experienced a significant increase in systo

78 -term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory.

79 MDP) within the prostate bed was found after cryoablation for prostate carcinoma.

80 o review the evolution and current status of cryoablation for renal tumors.

81 sults of the first clinical studies of focal cryoablation for select patients with low volume and low

82 rt our results using argon-based endocardial cryoablation for the treatment of AF in patients undergo

83 he acute procedural success rate of catheter cryoablation for this arrhythmia may be slightly lower t

84 No patients in the cryoablation group required any additional or alternate

85 nyl (165.0 microg [RF group] vs 75.0 microg [cryoablation group]; P < .001) and midazolam (2.9 mg [RF

86 and midazolam (2.9 mg [RF group] vs 1.6 mg [cryoablation group]; P = .026).

87 n 23 patients with AT, using inferomedial RA cryoablation (Group 1, n=8) and modified RA maze procedu

88 for systemic inflammation, rats treated with cryoablation had either immediate resection of the ablat

89 RFA and cryoablation have each been used for renal tissue ablati

90 Methods such as chemical ablation, cryoablation, high-temperature ablation (radiofrequency,

91 sis was seen on angiography after epicardial cryoablation in 1 patient.

92 ent; transcoronary alcohol in 6 and surgical cryoablation in 2 patients), acute success (noninducibil

93 cy ablation was conducted in 17 patients and cryoablation in 27, with comparable success rates (82% r

94 the size of the necrotic area after hepatic cryoablation in normal pig liver.

95 irrigated radiofrequency ablation in one and cryoablation in the other) and ablation within the middl

96 ing percutaneous radiofrequency ablation and cryoablation in the treatment of renal cell carcinoma ar

97 Mean blood loss from percutaneous cryoablation in this model was between that for RF ablat

98 ; irreversible electroporation, in five; and cryoablation, in one.

99 Percutaneous cryoablation is a minimally invasive procedure for tumor

100 Catheter cryoablation is a safe and clinically effective method f

101 For many cardiac arrhythmias, catheter cryoablation is a safe and effective alternative to radi

102 ioventricular block is substantial, catheter cryoablation is a safe and effective alternative to radi

103 Percutaneous cryoablation is a safe and effective method for palliati

104 Cryoablation is a safe and reasonably effective alternat

105 Although cryoablation is currently used to treat a targeted tumor

106 CT-monitored percutaneous cryoablation is feasible and safe in this pig liver mode

107 Renal cryoablation is most commonly performed percutaneously o

108 ancer-specific survival of 98%, laparoscopic cryoablation is safe and can be performed with minimal i

109 Adrenal cryoablation is technically feasible with a high rate of

110 Cryoablation is the most evaluated probe ablative method

111 Renal cryoablation is the most studied of all the energy based

112 Cryoablation led to a decrease in diffuse reflectance ac

113 orescence for the real-time visualization of cryoablation lesions in blood-perfused cardiac muscle pr

114 ve interventions (hepatic chemoembolization, cryoablation, liver transplantation).

115 With adrenal cryoablation, local control was achieved following treat

116 tilizing bipolar radiofrequency ablation and cryoablation, long-term studies have demonstrated a sign

117 lthough the acute procedural success rate of cryoablation may not equal that of radiofrequency ablati

118 Five normal pig livers were treated with cryoablation monitored with US.

119 the safety and effectiveness of percutaneous cryoablation, monitored with computed tomography (CT), f

120 iod, 10 men (mean age, 66.5 years) underwent cryoablation of 11 renal lesions, and 14 patients (11 me

121 severe complication associated with hepatic cryoablation of 30% to 35% or more of liver parenchyma,

122 c resonance (MR) imaging-guided percutaneous cryoablation of 65 liver tumors (62 metastases, three he

123 cancer that CTLA-4 blockade cooperates with cryoablation of a primary tumor to prevent the outgrowth

124 Cryoablation of both ventricular chambers eliminated Pur

125 Catheter cryoablation of common atrial flutter causes much less p

126 Cryoablation of either blood-perfused or saline-perfused

127 Cryoablation of extrinsic sympathovagal nerves eliminate

128 Cryoablation of human HER2(+) D2F2/E2 tumor enabled the

129 Following percutaneous cryoablation of liver tumors, alterations in liver enzym

130 Cryoablation of neu(+) TUBO tumor in BALB/c mice resulte

131 MR imaging-guided focal cryoablation of recurrent prostate cancer after radiatio

132 ds of patients who underwent RF ablation and cryoablation of renal tumors from June 19, 2003, to Febr

133 Cryoablation of renal tumors with ultrasound monitoring

134 Image-guided percutaneous cryoablation of small (< or = 4-cm) renal lesions appear

135 Currently, cryoablation of small renal lesions is minimally invasiv

136 Cryoablation of small renal masses represents an alterna

137 AT undergoing Fontan revision are compared: cryoablation of the inferomedial right atrium (RA), and

138 ons in 0.5 to 2 mm thick tissues relevant to cryoablation of the pulmonary vein (PV).

139 ssue tissue thermocouples profiles during 53 cryoablations of 40 PVs were analyzed.

140 Two complications occurred in a total of 27 cryoablations: one hemorrhage, which required a blood tr

141 Because cryoablation only delayed but did not prevent sustained

142 r ventricular tachycardia underwent catheter cryoablation or radiofrequency ablation.

143 Sprague-Dawley rats underwent 35% hepatic cryoablation or RFA and were killed at 1, 2, and 6 hours

144 epicardial window (Epi-window), or surgical cryoablation (OR-Cryo; age, 62+/-11 years; VT storm in 5

145 nd metastatic progression also seem to favor cryoablation over radio frequency ablation (4.6 vs. 11.7

146 own pathology for SRMs undergoing RFA versus cryoablation (P < 0.0001).

147 le success rates (82% radiofrequency vs. 85% cryoablation, p = 1.0).

148 Cryoablation patients had significantly improved symptom

149 Adrenal cryoablation patients who were not premedicated with an

150 .01) when compared with the cohort of kidney cryoablation patients.

151 Cryoablation performed laparoscopically or percutaneousl

152 uster (24.03 cm3), followed by those for the cryoablation probe (17.46 cm3) and single RF electrode (

153 and 3.98 cm, respectively), followed by the cryoablation probe (2.38 and 3.94 cm) and single RF elec

154 l as between the single RF electrode and the cryoablation probe (P < .001).

155 or with the RF electrode cluster versus the cryoablation probe (P = .381).

156 electrode (9.05 cm3) (single RF electrode vs cryoablation probe, P < .05).

157 ngle RF electrode, RF electrode cluster, and cryoablation probe, respectively.

158 Effectiveness of the cryoablation procedure versus drug therapy was determine

159 systolic blood pressure increase during the cryoablation procedure when compared with their counterp

160 the epicardial surface using an endocardial cryoablation procedure, and a 12-mm barrier with a 1.5-m

161 s during the final, active thaw phase of the cryoablation procedure, and one patient developed hypert

162 2.6 cm) in 23 patients were treated with 27 cryoablation procedures by using a protocol approved by

163 ring system was then applied to all 73 renal cryoablation procedures performed during 2012.

164 All 398 renal cryoablation procedures performed from 2003 through 2011

165 Thirty-eight (95%) of 40 cryoablation procedures were technically successful.

166 Cryoablation produced acute isolation of three or more P

167 nephrectomy and ablative procedures such as cryoablation, radiofrequency ablation, and recently radi

168 d SCID mice when CpG was incorporated in the cryoablation regimen, showing significant local control

169 The patient who underwent cryoablation remains free of arrhythmias.

170 In adult hearts, cryoablation resulted in c-kit-EGFP(+) expression, peaki

171 7 rabbits after left ventricular endocardial cryoablation, resulting in a thin layer of surviving epi

172 Currently available data suggest that cryoablation results in lower retreatments (P < 0.0001),

173 lation targets while identifying sites where cryoablation should be avoided.

174 Histologic lung sections after cryoablation showed multiple foci of perivenular inflamm

175 The loss of electrical activity within the cryoablation site exhibited a close spatial correlation

176 Tabletop argon gas-based cryoablation system with a double-freeze-thaw protocol w

177 performed more often for lesions treated by cryoablation than RFA with a significantly higher rate o

178 Before cryoablation, the mean score for worst pain in a 24-hour

179 These data suggest that peripheral retinal cryoablation therapy is an effective treatment for activ

180 After cryoablation, there was increased echogenicity at US and

181 Skeletal injuries were coupled with cryoablation to create non-healing osteonecrotic defects

182 covery of CMAP amplitude after discontinuing cryoablation took <60 seconds in all cases.

183 Electron microscopy of cryoablation-treated liver tissue demonstrated disruptio

184 ngle renal tumor, underwent one percutaneous cryoablation treatment session that combined ultrasonogr

185 Twenty dogs underwent cryoablation using 28-mm cryoballoon, 6 dogs were done u

186 Cryoablation using this flexible argon-based device for

187 tokine levels were significantly elevated in cryoablation versus RFA animals.

188 Cryoablation was associated with a significantly lower d

189 Cryoablation was associated with higher success rates an

190 30% decrease in CMAP amplitude occurred and cryoablation was discontinued.

191 on, the 30% reduction cutoff was reached and cryoablation was discontinued.

192 Hepatic cryoablation was performed in 12 rabbits with VX2 tumors

193 Cryoablation was performed in 2 patients, and radiofrequ

194 Surgical right ventricular outflow tract cryoablation was performed in 22 patients (10.7%).

195 Cryoablation was performed in 26 patients with a signifi

196 Surgical cryoablation was performed in 3 patients and abolished V

197 Cryoablation was terminated on any perceived reduction i

198 Mean (MC)2 risk score for all renal cryoablations was 4.7 (standard deviation, 1.9; range, 2

199 mammography and US before, during, and after cryoablation were assessed to categorize densities and m

200 m colorectal cancer amenable to resection or cryoablation were eligible.

201 who underwent kidney (not in the upper pole) cryoablation (Wilcoxon rank sum test).

202 gy evolves it is likely that the efficacy of cryoablation will improve and the list of arrhythmias th

203 /neu humoral and cellular immunity following cryoablation with or without peritumoral CpG injection w

204 Percutaneous cryoablation with US guidance and CT monitoring is safe